Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells.
about
Research progress on the anticarcinogenic actions and mechanisms of ellagic acid.The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells.The human gut microbial ecology associated with overweight and obesity determines ellagic acid metabolism.Gut microbiota modulation of chemotherapy efficacy and toxicity.Potential antiproliferative activity of polyphenol metabolites against human breast cancer cells and their urine excretion pattern in healthy subjects following acute intake of a polyphenol-rich juice of grumixama (Eugenia brasiliensis Lam.).Antiproliferative activity of the ellagic acid-derived gut microbiota isourolithin A and comparison with its urolithin A isomer: the role of cell metabolism.Urolithins, the rescue of "old" metabolites to understand a "new" concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status.Prebiotic nut compounds and human microbiota.Improvements in Metabolic Health with Consumption of Ellagic Acid and Subsequent Conversion into Urolithins: Evidence and Mechanisms.Metabolism and growth inhibitory activity of cranberry derived flavonoids in bladder cancer cells.Urolithin A suppresses the proliferation of endometrial cancer cells by mediating estrogen receptor-α-dependent gene expression.Synthesis of natural urolithin M6, a galloflavin mimetic, as a potential inhibitor of lactate dehydrogenase A.Urolithins impair cell proliferation, arrest the cell cycle and induce apoptosis in UMUC3 bladder cancer cells.Effects on Nitric Oxide Production of Urolithins, Gut-Derived Ellagitannin Metabolites, in Human Aortic Endothelial Cells.Human Gut Microbiota and Gastrointestinal Cancer.Urolithin A, C, and D, but not iso-urolithin A and urolithin B, attenuate triglyceride accumulation in human cultures of adipocytes and hepatocytes.
P2860
Q33802503-DCACDCAA-8993-4A6E-B4F5-8341C77C671FQ35598535-B958A23B-04F4-4E4A-B8A0-D514FCBFD7BAQ35849074-C5861165-7E67-4688-A192-21B2692F33E1Q36300217-E0BC7ADB-57CB-402E-B25D-3AEBD7BEED40Q38702341-2889084B-82AE-4A07-9F40-B46E6B9248B1Q38810847-F414047A-4E79-488A-92BC-9FFA60954297Q38829534-B7D16430-0795-4D6A-8754-4580C08F5473Q38844211-0CFB000E-D7CE-4C76-B015-85D827AA1FE5Q38955416-043E80C8-A0F9-4E5D-A9CA-7262AA59B56CQ39316032-A6FACA51-6B84-458B-8D97-87C666611270Q42838878-6FBDC373-43C4-49A1-B2FE-CBAD8FE141E8Q48053265-54615350-2147-4164-9D26-9EA2D611485DQ48253399-BDB2A135-8AA8-4AAB-BF58-9B31224A7C29Q49137384-92A101F0-D03C-4E7B-B979-362104FBF846Q52374120-E36B1A61-343A-44D7-80C9-204C34A298CEQ55030892-88DDF1E4-FBBD-4D57-824D-3DE570628612
P2860
Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Phase-II metabolism limits the ...... s in human colon cancer cells.
@en
Phase-II metabolism limits the ...... s in human colon cancer cells.
@nl
type
label
Phase-II metabolism limits the ...... s in human colon cancer cells.
@en
Phase-II metabolism limits the ...... s in human colon cancer cells.
@nl
prefLabel
Phase-II metabolism limits the ...... s in human colon cancer cells.
@en
Phase-II metabolism limits the ...... s in human colon cancer cells.
@nl
P2093
P2860
P50
P1476
Phase-II metabolism limits the ...... s in human colon cancer cells.
@en
P2093
Antonio González-Sarrías
Francisco A Tomás-Barberán
Juan Antonio Giménez-Bastida
Mar Larrosa
María Teresa García-Conesa
María Ángeles Núñez-Sánchez
P2860
P2888
P304
P356
10.1007/S00394-013-0589-4
P50
P577
2014-04-01T00:00:00Z